Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Banner Corp
BANR
$2.5B
| $33.8M | ﹤0.01% |
613,026
+10,327
| +2% | +$556K |
|
1602
AeroVironment
AVAV
$9.46B
| $33.8M | ﹤0.01% |
391,832
+1,164
| +0.3% | +$113K |
|
|
MAXR
1603
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $33.8M | ﹤0.01% |
1,193,644
+1,448
| +0.1% | +$46.5K |
|
|
SILK
1604
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $33.6M | ﹤0.01% |
611,259
+21,200
| +4% | +$1.11M |
|
1605
Relay Therapeutics
RLAY
$4.42B
| $33.6M | ﹤0.01% |
1,065,260
+357,365
| +50% | +$12M |
|
1606
Acadia Pharmaceuticals
ACAD
$5B
| $33.6M | ﹤0.01% |
2,021,152
-54,148
| -3% | -$1.04M |
|
|
RVNC
1607
DELISTED
Revance Therapeutics, Inc.
RVNC
| $33.6M | ﹤0.01% |
1,204,388
+577
| +0% | +$16.5K |
|
1608
Gray Television
GTN
$513M
| $33.5M | ﹤0.01% |
1,470,158
+42,946
| +3% | +$950K |
|
1609
GrafTech
EAF
$204M
| $33.5M | ﹤0.01% |
324,697
+54,979
| +20% | +$6.01M |
|
|
ODP
1610
DELISTED
ODP
ODP
| $33.5M | ﹤0.01% |
834,105
-52,385
| -6% | -$2.36M |
|
1611
Healthcare Services Group
HCSG
$1.45B
| $33.5M | ﹤0.01% |
1,340,194
-20,413
| -2% | -$552K |
|
1612
Xencor
XNCR
$1.69B
| $33.4M | ﹤0.01% |
1,023,994
+24,537
| +2% | +$806K |
|
1613
Adeia
ADEA
$3.13B
| $33.4M | ﹤0.01% |
6,706,480
-249,090
| -4% | -$1.34M |
|
1614
Credicorp
BAP
$29.7B
| $33.4M | ﹤0.01% |
303,173
-13,075
| -4% | -$1.43M |
|
1615
Lakeland Financial Corp
LKFN
$1.56B
| $33.4M | ﹤0.01% |
468,806
+9,332
| +2% | +$607K |
|
|
B
1616
DELISTED
Barnes Group Inc.
B
| $33.4M | ﹤0.01% |
800,189
+6,725
| +0.8% | +$320K |
|
1617
Renasant Corp
RNST
$3.99B
| $33.4M | ﹤0.01% |
925,702
-62,923
| -6% | -$2.24M |
|
1618
Enpro
NPO
$7.22B
| $33.3M | ﹤0.01% |
382,345
+17,336
| +5% | +$1.52M |
|
1619
Monro
MNRO
$364M
| $33.3M | ﹤0.01% |
578,769
+1,492
| +0.3% | +$87.5K |
|
|
DEA
1620
Easterly Government Properties
DEA
$1.17B
| $33.3M | ﹤0.01% |
644,402
-30,762
| -5% | -$1.66M |
|
|
CVSA
1621
Covista Inc
CVSA
$4.45B
| $33.3M | ﹤0.01% |
879,827
-5,268
| -0.6% | -$195K |
|
1622
Vroom Inc
VRM
$52.3M
| $33.2M | ﹤0.01% |
18,803
+9,102
| +94% | +$23.2M |
|
1623
Bumble
BMBL
$343M
| $33.2M | ﹤0.01% |
663,966
+124,260
| +23% | +$6.46M |
|
1624
ESCO Technologies
ESE
$7.77B
| $33.2M | ﹤0.01% |
430,891
+2,774
| +0.6% | +$245K |
|
1625
Pricesmart
PSMT
$5.54B
| $33.1M | ﹤0.01% |
427,224
+3,061
| +0.7% | +$260K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.